54 COMPANY PERSPECTIVE
The future of personal care ingredient R&D
Raquel Delgado, Paola Pérez - Lubrizol
Lubrizol is a classic example of the change and growth that has taken place in the personal care market in the last 25 years. In 2000, Barcelona-based Lipotec was known in the industry for research, development and production of innovative active ingredients and delivery systems for application in skin care and cosmetics. That industry leadership has only grown since Lubrizol’s acquisition of Lipotec skin care actives in 2012. Today, Lubrizol continues to partner with
customers to develop, manufacture and market a broad range of differentiated ingredients and formulations for skin care, hair care and skin cleansing. As early and enthusiastic adopters of data science, AI and other technology, Lubrizol has furthered innovation in countless ways in the last quarter of a century. For example, computer vision capabilities
combined with AI allow Lubrizol scientists to analyse a larger number of images in a fraction of the time it would take to analyse them manually. A large volunteer database compiled by Lubrizol at sites in Spain and China now provides a wide variety of skin and hair images, giving researchers more ways to test and deliver fast results. Lubrizol, a global specialty chemical leader,
has an extensive portfolio of products that goes well beyond the beauty segment and has a deep reserve of research expertise. With 100+ facilities, serving 100+ countries, Lubrizol R&D teams have global support and opportunities for cross- disciplinary projects that enlighten and elevate the work of individual research groups. And while product innovations and customer
demand are vastly different now compared to 2000, Lubrizol’s emphasis on R&D and innovation has not changed. A snapshot of 25 years shows the ways research and product development have evolved and expanded.
Innovation gained industry attention Before being acquired by Lubrizol in 2012, Barcelona-based Lipotec was known for its research, development and production of active ingredients and delivery systems for skin care. The company’s success soared even higher with the development of the anti-aging peptide Argireline™.
PERSONAL CARE August 2025
The original Argireline is still in high demand,
as is the next-generation innovation, Argireline Amplified peptide, developed by a Lubrizol team addressing the 12 Principles of Green Chemistry and launched in 2020. Argireline Amplified peptide is a particular point of pride for Lubrizol, as it is a truly sustainable solution that delivers multiple benefits to the skin, like firmness, volume, and lifting to skin in only five days. Leveraging Lubrizol and Lipotec technical
team enabled Lubrizol to advance speed- to-market capabilities and serve an even larger base of customers, adding hair care and skin cleansing to the list of applications for customers.
In vitro, in vivo in Barcelona, Shanghai and beyond Lubrizol expanded its R&D and lab network in Asia Pacific and significantly boosted global beauty research capabilities last year with the opening of the Lubrizol Beauty Research Institute in Shanghai. While Barcelona remains a major beauty research hub, the Shanghai site
enables the company to further growin vivo beauty testing capabilities. The Beauty Research Institute leveraging
AI and automation in Barcelona and Shanghai offers: ■ Multiethnic panellists ■ 3D imaging devices ■ Proprietary computer vision techniques ■ Innovative testing protocols
In vitro and in vivo assays evaluate the performance of the active efficacy
www.personalcaremagazine.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114
